axitinib,sunitinib,pembrolizumab
pfizer,merck
['sunitinib', 'bladder', 'keynote426', 'key,note,42', 'axitinib', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'key,note,426']
#kidneybladder oral session continues with presenting #keynote426 phase 3 long term 5 year follow up showing persistent benefit of #axitinib + #pembro vs #sunitinib in metastatic#rcc #asco23 
Medical Oncologist, Investigator, Chief, #BladderCancer Section, #GenitourinaryTumors, NCI, NIH #RareTumors #PatientAdvocate, Latina. Views are my own